🇺🇸 FDA
Patent

US 8236288

Melanin modification compositions and methods of use

granted A61KA61K2800/92A61K31/047

Quick answer

US patent 8236288 (Melanin modification compositions and methods of use) held by SkinMedica, Inc. expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SkinMedica, Inc.
Grant date
Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2800/92, A61K31/047, A61K31/07, A61K31/122